Woburn, Mass., December 20–LASE Innovation, a developer of the groundbreaking LP Cell Barcoding™ platform for next generation single-cell analysis announced the appointment of Trevor Brown as Chief Commercial Officer.
“We are excited to have Trevor join LASE Innovation at this critical juncture. We’ve spent the past four years de-risking and demonstrating the potential of our LP Cell Barcoding platform and have published some of our game-changing flow cytometry applications in a recent Nature Biomedical Engineering article. We are ready to start building out our commercial strategy over the coming year,” said Sheldon J.J. Kwok, CEO and co-founder of LASE Innovation. “Trevor has an extensive background in executing commercial strategies with novel technologies in the life sciences, having led new product development and commercialization across both Fortune 500 and startup companies and has deep experience building and leading commercial go-to-market efforts.”
Prior to joining LASE Innovation, Mr. Brown was VP/GM of LUMICKS where he led the commercial scaling of their North America operations. Mr. Brown previously founded and led the Precision Medicine business unit of SeraCare Life Sciences, helping them achieve a successful exit to LGC in 2018. Mr. Brown has also held senior commercial roles across product-led companies such as Luminex, BD Biosciences and Bio-Rad Laboratories and is Managing Partner of the consulting firm Precision Health Strategy Partners.
“When I first met Sheldon and LASE earlier this year, I was amazed at the potential for this optical-based barcoding technology to track individual cells across platforms such as flow cytometry, imaging, and in vivo approaches. This is the next generation of single cell technology that will allow researchers to probe cellular dynamics, responses to treatment and behavioral phenotypes at scale. It is the perfect time to join LASE to help them bring this to market.” said Mr. Brown.
About LASE Innovation
LASE Innovation, founded in 2018 and based in Boston, is advancing biomedical research with their patented LP Cell Barcoding™ technology, enabling massively multiplexed barcoding of cells and the unprecedented ability to connect data across multiple single cell and omics platforms including flow cytometry, imaging and RNA-sequencing. LASE Innovation is in the late stages of development of their flagship LASE Cytometer and LP tagging technology enabling Time-lapse flow™ and Multi-pass flow™ cytometry applications that promise to revolutionize how users approach flow cytometry experiments and researchers connect their data across the myriad of platforms leading to accelerated discoveries for health and disease.